Author: Fard, Mahin Behzadi; Fard, Samaneh Behzadi; Ramazi, Shahin; Atashi, Amir; Eslamifar, Zahra
Title: Thrombosis in COVID-19 infection: Role of platelet activation-mediated immunity Cord-id: uir42kfs Document date: 2021_8_23
ID: uir42kfs
Snippet: BACKGROUND: Thrombosis plays an important role in the Coronavrus Disease 2019 (COVID-19) infection-related complications such as acute respiratory distress syndrome and myocardial infarction. Multiple factors such as oxygen demand injuries, endothelial cells injury related to infection, and plaque formation. MAIN BODY: Platelets obtained from the patients may have severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA, showing that the increased activation potential recommends platelet
Document: BACKGROUND: Thrombosis plays an important role in the Coronavrus Disease 2019 (COVID-19) infection-related complications such as acute respiratory distress syndrome and myocardial infarction. Multiple factors such as oxygen demand injuries, endothelial cells injury related to infection, and plaque formation. MAIN BODY: Platelets obtained from the patients may have severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA, showing that the increased activation potential recommends platelet can be hyper-activated in severely ill SARS-CoV-2 cases. Platelets contain multiple receptors that interact with specific ligands. Pathogen’s receptors such as Toll-like receptors (TLRs), NOD-like receptor, C-type lectin receptor family, glycoprotein (GP) such as GPαIIbβ3 and GPIbα which allow pathogens to interact with platelets. Platelet TLRs and NOD2 are involved in platelet activation and thrombosis. Accordingly, TLRs are critical receptors that could recognize various endogenous damage-associated molecular patterns and exogenous pathogen-associated molecular patterns (PAMPs). TLRs are considered as important components in the activation of innate immunity response against pathogenic and non-pathogenic components like damaged tissues. TLRs-1,-2,-4,-6,-7 expression on or within platelets has been reported previously. Various PAMPs were indicated to be capable of binding to platelet-TLRs and inducing both the activation and promotion of downstream proinflammatory signaling cascade. CONCLUSION: It is possible that the increased TLRs expression and TLR-mediated platelets activation during COVID-19 may enhance vascular and coronary thrombosis. It may be hypothesized using TLRs antagonist and monoclonal antibody against P-selectin, as the marker of leukocyte recruitment and platelet activation, besides viral therapy provide therapeutic advances in fighting against the thrombosis related complications in COVID-19.
Search related documents:
Co phrase search for related documents- activation induce and acute ards respiratory distress syndrome: 1, 2
- activation induce and acute lung injury: 1, 2
- activation induce and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- activation induce and adaptive innate immune response: 1, 2, 3
- activation induce and adaptive innate immunity: 1, 2, 3, 4, 5, 6
- activation induce and adaptor protein: 1, 2
- activation leukocyte recruitment and acute ards respiratory distress syndrome: 1, 2
- activation leukocyte recruitment and acute lung injury: 1
- activation leukocyte recruitment and adaptive innate: 1, 2
- activation leukocyte recruitment and adaptive innate immunity: 1
- activation marker and acute ards respiratory distress syndrome: 1, 2
- activation marker and adaptive innate: 1, 2
- activation marker and adaptive innate immunity: 1
- activation platelet adhesion and acute ards respiratory distress syndrome: 1
- active platelet and acute ards respiratory distress syndrome: 1
- active platelet and acute lung injury: 1
- active platelet and acute lung injury pathogenesis: 1
- acute ards respiratory distress syndrome and adaptive innate immunity: 1, 2, 3, 4, 5
- acute ards respiratory distress syndrome and adaptor protein: 1
Co phrase search for related documents, hyperlinks ordered by date